BioPharma Dive 24. Nov. 2025 Biogen strikes deal with Versant-backed biotech to expand immune portfolio #Dayra Therapeutics #Versant-backed biotech
BioPharma Dive 21. Nov. 2025 A brain biotech’s top drug fails against MS #Contineum Therapeutics #Therapeutics dipped